Delivery Order SPE2DB24D9144-SPE2DB25FCMTM
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Mirena 52 mg systems, with a ceiling value of $1,041.56. The award, issued on August 6, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 27, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,124.68 by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Mirena 52 mg contraceptive systems. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 7, 2025, and carries no set-aside designation. This award represents a single transaction under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,041.56 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This firm fixed-price delivery order was issued on May 30, 2025, with an ultimate completion date of June 23, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete as a woman-owned small business in the open federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a $2,083.12 firm fixed-price delivery order by the Defense Logistics Agency for Mirena 52 mg contraceptive systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a specific purchase order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion and valid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, valued at $9,967.38, represents performance through September 25, 2025, and carries no set-aside designation. The award utilizes DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. The contract, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order without a set-aside designation. This award represents a direct delivery under DMS Pharmaceutical Group's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $4,166.24, was awarded on June 2, 2025, with an ultimate completion date of June 24, 2025. The contract utilizes no set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at approximately $12.5K by the Defense Logistics Agency (DLA) on July 25, 2025, for Mirena 52 mg systems with an ultimate completion date of August 15, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $2,083.12 from the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The contract calls for the delivery of Mirena 52 mg contraceptive systems, with an ultimate completion date of August 11, 2025. This delivery order was issued without a set-aside designation and represents a single transaction under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $5,207.70 with an ultimate completion date of August 21, 2025, was issued without a set-aside designation. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- SPE2DB24D9144Indefinite Delivery Contract
- SPE2DB24D9144-SPE2DB25FCMTMDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,645.00 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Mirena 52 mg contraceptive systems. The contract utilizes firm fixed-price pricing with an ultimate completion date of June 24, 2025, and is not designated as a set-aside award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at approximately $500 million and extending through November 2026, which enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical and medical supply products supporting Department of Defense healthcare facilities. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio delivering branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems nationwide. The company's track record includes distribution of specialized pharmaceutical products ranging from oncology treatments to contraceptive devices and vaccines. This particular delivery order for Mirena systems represents a routine execution of the broader IDC framework, ensuring the continued availability of essential pharmaceutical inventory for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 6/2/25 |